Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple pill ease stent discomfort? new trial tests two options

NCT ID NCT06966804

Symptom relief Sponsor: Penang Hospital, Malaysia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study tests whether two common blood pressure drugs, terazosin and tamsulosin, can reduce urinary symptoms like pain and urgency after a ureteral stent is placed. 150 adults in Malaysia will be randomly assigned to take one of the drugs or receive standard care for 14 days. Researchers will track symptom scores and painkiller use to see which approach works best.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Terazosin and Tamsulosin (alpha-blocker drugs)
What this could lead to
If successful, this could show that a short course of an alpha-blocker drug reduces uncomfortable urinary symptoms after stent placement, improving patient comfort.
What could go wrong
This is a moderate-sized trial (150 people) comparing two drugs to no drug, so results may not apply to all patients. Side effects from the drugs are possible, and the benefit may be small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Malaysian age 18 years old and above. 2. Able to provide written informed consent to participate in the trial. 3. Willing to comply with study procedures. 4. Unilateral intracorporeal lithotripsy procedure with ureteral stent placement for uncomplicated ureteric or renal calculi Exclusion Criteria: 1. Known comorbidity that increase the risk of complication 1. Prostate pathology: Benign prostate hyperplasia, prostatitis, prostatic carcinoma 2. Bladder pathology: Bladder tumor, stone, overactive bladder 3. Ureteral abnormality/ trauma, urethral stricture 4. Concomitant urinary tract infection 5. Orthostatic hypotension 6. Solitary kidney 2. Previous pelvic/ gynaecological surgery 3. Patient is concomitantly receiving treatment from a pain clinic for chronic pain management. 4. Pregnancy (for women of childbearing potential) 5. Known history of allergic reactions to tamsulosin or terazosin 6. Patient is concomitantly taking warfarin or H2 receptor blockers 7. Patients with clinical condition(s) judged by the researcher/ clinician to be unsuitable for participation in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Renal calculi are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

nephrolithiasis ureterolithiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stent related symptoms

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital Pulau Pinang

    RECRUITING

    George Town, Pulau Pinang, 10450, Malaysia

  • Sultanah Bahiyah Hospital, Alor Setar

    RECRUITING

    Alor Star, Kedah, 05460, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.